Total Payments
$2,872
2024 Payments
$1,339
Companies
11
Transactions
144
Medicare Patients
417
Medicare Billing
$142,770
Payment Breakdown by Category
Food & Beverage$2,872 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,872 | 144 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $893.85 | 48 | $0 (2024) |
| Lundbeck LLC | $716.06 | 36 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $437.96 | 21 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $198.45 | 9 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $179.82 | 9 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $125.01 | 4 | $0 (2024) |
| ITI, Inc. | $106.05 | 6 | $0 (2022) |
| Alkermes, Inc. | $67.55 | 3 | $0 (2024) |
| Axsome Therapeutics, Inc. | $53.07 | 3 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $52.19 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,339 | 63 | Lundbeck LLC ($361.33) |
| 2023 | $851.21 | 44 | ABBVIE INC. ($377.51) |
| 2022 | $413.00 | 21 | Lundbeck LLC ($121.61) |
| 2021 | $268.96 | 16 | AbbVie Inc. ($96.31) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $15.98 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/12/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $25.71 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $24.74 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.09 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $18.45 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $34.82 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $17.73 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $36.95 | General |
| Category: SCHIZOPHRENIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 131 | 398 | $60,290 | $22,308 |
| 2022 | 6 | 286 | 1,519 | $240,015 | $120,462 |
Total Patients
417
Total Services
1,917
Medicare Billing
$142,770
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 214 | $39,730 | $15,345 | 38.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 63 | 184 | $20,560 | $6,963 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 740 | $136,900 | $72,174 | 52.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 92 | 676 | $78,300 | $35,377 | 45.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 42 | 42 | $11,400 | $5,628 | 49.4% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2022 | 26 | 26 | $6,790 | $3,422 | 50.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $4,400 | $2,609 | 59.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 17 | 19 | $2,225 | $1,252 | 56.2% |
About Eric Yenchi
Eric Yenchi is a Psychiatric/Mental Health, Child & Adolescent healthcare provider based in Clinton, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/10/2018. The National Provider Identifier (NPI) number assigned to this provider is 1346723970.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eric Yenchi has received a total of $2,872 in payments from pharmaceutical and medical device companies, with $1,339 received in 2024. These payments were reported across 144 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($2,872).
As a Medicare-enrolled provider, Yenchi has provided services to 417 Medicare beneficiaries, totaling 1,917 services with total Medicare billing of $142,770. Data is available for 2 years (2022–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health, Child & Adolescent
- Other Specialties Child & Adolescent|Psychiatric/Mental Health|Psychiatric/Mental Health
- Location Clinton, MD
- Active Since 09/10/2018
- Last Updated 09/01/2021
- Taxonomy Code 163WP0807X
- Entity Type Individual
- NPI Number 1346723970
Products in Payments
- VRAYLAR (Drug) $893.85
- REXULTI (Drug) $728.18
- CAPLYTA (Drug) $304.50
- ABILIFY MAINTENA (Drug) $228.02
- INGREZZA (Drug) $179.82
- BRINTELLIX (Drug) $109.01
- FANAPT (Drug) $90.19
- ABILIFY ASIMTUFII (Drug) $88.81
- ARISTADA (Drug) $67.55
- Auvelity (Drug) $53.07
- Qelbree (Drug) $52.19
- COBENFY (Drug) $41.69
- HETLIOZ (Drug) $34.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.